Wu, Edwin S.C.,Chiu, Peter J.S.,Hsu, Mei-chi,Shih, Ying-Chu
申请号：
AU2016235093
公开号：
AU2016235093A1
申请日:
2016.03.24
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The present invention relates to new medical uses of morphinans such as naltrexone, nalmefene and their related derivatives. The present invention relates to Toll-like receptor 4 (TLR4) antagonist compounds, and pharmaceutical formulations thereof, and use thereof for prevention and treatment of autoimmune liver diseases including but not limited to autoimmune hepatitis.
